US EditionPLL Therapeutics to present ALS research strategy at Bioshares Biotech Summit - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PLL Therapeutics to present ALS research strategy at Bioshares Biotech Summit - Pharmafile
French biotech, PLL Therapeutics, will present its approach to early detection and treatment of Amyotrophic Lateral Sclerosis (ALS) at the Bioshares Biotech Summit in Hobart, Australia. The presentation forms part of the summit’s “What the Heck Biotech!” session, focusing on novel therapeutic strategies. PLL Therapeutics is currently progressing a phase 1 clinical trial in ALS. […] The post PLL Therapeutics to present ALS research strategy at Bi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
